Stephen Connelly - Jan 2, 2024 Form 4 Insider Report for Equillium, Inc. (EQ)

Role
Chief Scientific Officer, Director
Signature
/s/ Jason A. Keyes, Attorney -in-Fact for Stephen Connelly
Stock symbol
EQ
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 06:17 PM
Previous filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQ Employee Stock Option (right to buy) Award $0 +175K $0.00 175K Jan 2, 2024 Common Stock 175K $0.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.